- Home
- / Avanir Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Avanir Pharmaceuticals financials data including stock price, CreditSafe score, balance sheet, and cash flow.
CreditSafe Score
?
Score changed on Jun 14, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2013 | FY, 2014 |
|---|---|---|
| Cash | 55.3M | 271.9M |
| Accounts Receivable | 12.5M | 22.8M |
| Current Assets | 71.8M | 300.8M |
| PP&E | 1.6M | 3.6M |
| Total Assets | 76.1M | 307.0M |
| Accounts Payable | 5.9M | 6.7M |
| Current Liabilities | 34.8M | 32.1M |
| Additional Paid-in Capital | 519.0M | 824.3M |
| Retained Earnings | (500.5M) | (551.0M) |
| Total Equity | 18.5M | 273.4M |
| Financial Leverage | 4.1 | 1.1 |